As the UK braces for what is anticipated to be its fifth intense heatwave this summer, the Medicines and Healthcare products Regulatory Agency (MHRA) has issued a critical warning regarding the use of common painkillers. According to the agency, medications such as ibuprofen and naproxen may increase individuals’ sensitivity to sunlight, thereby raising their risk of sunburn. With temperatures expected to reach a scorching 36°C next week, the public is urged to exercise caution.
Increased Sensitivity to the Sun
The MHRA’s alert comes as many Britons prepare for a week of sweltering heat. Dr Alison Cave, the chief safety officer at the MHRA, emphasised the importance of being aware of how certain medications can affect the body’s ability to cope with heat and sunlight exposure. “Some commonly used medicines can affect the body’s ability to stay hydrated, regulate temperature, or protect itself from sun exposure,” she noted, highlighting the need for simple yet effective precautions.
In addition to painkillers, several other types of drugs may heighten sun sensitivity. These include certain antibiotics like doxycycline and tetracycline, acne treatments such as isotretinoin and topical retinoids, as well as antifungal medicines like voriconazole. The combination of these medications with high temperatures could lead to serious health implications.
Vulnerable Groups at Greater Risk
The MHRA’s warning is particularly relevant for older adults and individuals with chronic health conditions, especially those suffering from heart or lung diseases. Those taking multiple medications are also at a higher risk of experiencing heat-related illnesses. Such individuals may find it more challenging to regulate body temperature due to the effects of their prescriptions.
Dr Nick Broughton, NHS England’s national director for mental health, learning disabilities and autism, reiterated the need for caution among people on specific mental health medications. He advised that those taking antipsychotics and antidepressants should remain vigilant during hot weather as these can impair the body’s cooling mechanisms. “Most importantly, they should not stop taking their medication suddenly,” he cautioned, encouraging individuals to consult their GP, pharmacist, or mental health team if they have concerns.
Precautions to Take
With yellow heat health alerts now in place across England, the public is reminded to take specific measures to mitigate the risks associated with heat and medication. The MHRA recommends checking the patient information leaflet provided with medications for guidance on sun exposure and hydration, which is available both in print and online.
Recognising the signs of heat distress is crucial. Symptoms may include dizziness, headaches, unusual fatigue, confusion, or reduced urination. Skin reactions such as redness, soreness, or blistering after sun exposure can also indicate heightened sensitivity due to medication.
It is vital that individuals do not abruptly discontinue their prescribed treatments without professional guidance. Those unsure about the interactions between their medications and heat should seek advice from healthcare professionals.
Why it Matters
As climate change continues to exacerbate extreme weather conditions, understanding the implications of our medications in such environments becomes increasingly vital. The MHRA’s warning serves as a crucial reminder for everyone, particularly vulnerable populations, to remain informed about how their health can be affected by the interplay between medication and environmental factors. By taking necessary precautions, individuals can better protect themselves and their loved ones during these challenging weather patterns.